Real-time three-dimensional myocardial contrast echocardiography: Is it clinically feasible?

European Journal of Echocardiography

Volumn 9, Issue 6, 2008, Pages 761-765

  Bhan, A ^a   Kapetanakis, S ^a   Rana, B S ^a   Ho, E ^a   Wilson, K ^a   Pearson, P ^a   Mushemi, S ^a   Deguzman, J ^a   Reiken, J ^a   Harden, M D ^a   Walker, N ^a   Rafter, P G ^b   Monaghan, M J ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

3D echo; Contrast; Myocardial perfusion

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE WALL MOTION; HEART MUSCLE PERFUSION; HUMAN; MALE; PRIORITY JOURNAL; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

AGED; AGED, 80 AND OVER; ECHOCARDIOGRAPHY, STRESS; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; FEASIBILITY STUDIES; FEMALE; HEART VENTRICLES; HUMANS; IMAGE ENHANCEMENT; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 54949144434     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1093/ejechocard/jen143     Document Type: Article

References (30)

1. Schneider M. SonoVue, a new ultrasound contrast agent. Eur Radiol 1999; 9:S347-8.
2. Schneider M, Arditi M, Barrau MB, Brochot J, Broillet A, Ventrone R et al. BR1: a new ultrasonographic contrast agent based on sulfur hexafluoride-filled microbubbles. Invest Radiol 1995;30:451-7.
3. Nanda NC, Wistran DC, Karlsberg RP, Hack TC, Smith WB, Foley DA et al. Multicenter evaluation of SonoVue for improved endocardial border delineation. Echocardiography 2002;19:27-36.
4. Brochet E. Left ventricular opacification and stress echocardiography. Ann Cardiol Angeiol (Paris) 2002;51:212-3.
5. Fang LG. The effect of SonoVue in endocardial border delineation and myocardial perfusion. Zhonghua Nei Ke Za Zhi 2004;43:824-7.
6. Nahar T, Li P, Kuersten B, Batra S, Vannan MA. Detection of resting myocardial perfusion defects by SonoVue myocardial contrast echocardiography. Echocardiography 2003;20:511-7.
7. Rovai D, Morales MA, Amyot R, L'Abbate A. Clinical experience with SonoVue in myocardial perfusion imaging. Echocardiography 2000;17:S17-23.
8. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
9. Hancock J, Dittrich H, Jewitt DE, Monaghan MJ. Evaluation of myocardial, hepatic, and renal perfusion in a variety of clinical conditions using an intravenous ultrasound contrast agent (Optison) and second harmonic imaging. Heart 1999;81:636-41.
10. Dijkmans PA, Senior R, Becher H, Porter TR, Wei K, Visser CA et al. Myocardial contrast echocardiography evolving as a clinically feasible technique for accurate, rapid, and safe assessment of myocardial perfusion: the evidence so far. J Am Coll Cardiol 2006;48:2168-77.
11. Jucquois I, Nihoyannopoulos P, D'Hondt AM, Roelants V, Robert A, Melin JA et al. Comparison of myocardial contrast echocardiography with NC100100 and (99 m)Tc sestamibi SPECT for detection of resting myocardial perfusion abnormalities in patients with previous myocardial infarction. Heart 2000;83:518-24.
12. Muro T, Hozumi T, Watanabe H, Yamagishi H, Yoshiyama M, Takeuchi K et al. Assessment ofmyocardial perfusion abnormalities by intravenous- myocardial contrast echocardiography with harmonic power Doppler imaging: comparison with positron emission tomography. Heart 2003;89:145-9.
13. Tsutsui JM, Elhendy A, Anderson JR, Xie F, McGrain AC, Porter TR. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 2005;112:1444-50.
14. Tsutsui JM, Xie F, O'Leary EL, Elhendy A, Anderson JR, McGrain AC et al. Diagnostic accuracy and prognostic value of dobutamine stress myocardial contrast echocardiography in patients with suspected acute coronary syndromes. Echocardiography 2005;22:487-95.
15. Monaghan MJ. Contrast echocardiography: from left ventricular opacification to myocardial perfusion. Are the promises to be realised? Heart 2003;89:1389-90.
16. Jenkins C, Bricknell K, Hanekom L, Marwick TH. Reproducibility and accuracy of echocardiographic measurements of left ventricular parameters using real-time three-dimensional echocardiography. J Am Coll Cardiol 2004;44:878-86.
17. Kapetanakis S, Kearney MT, Siva A, Gall N, Cooklin M, Monaghan MJ. Realtime three-dimensional echocardiography: a novel technique to quantify global left ventricular mechanical dyssynchrony. Circulation 2005;112:992-1000.
18. De Castro S, Caselli S, Maron M, Pelliccia A, Cavarretta E, Maddukuri P et al. Left ventricular remodelling index (LVRI) in various pathophysiological conditions: a real-time three-dimensional echocardiographic study. Heart 2007;93:205-9.
19. Mannaerts HF, van der Heide JA, Kamp O, Stoel MG, Twisk J, Visser CA. Early identification of left ventricular remodelling after myocardial infarction, assessed by transthoracic 3D echocardiography. Eur Heart J 2004;25:680-7.
20. Matsumura Y, Hozumi T, Arai K, Sugioka K, Ujino K, Takemoto Yet al. Noninvasive assessment of myocardial ischaemia using new real-time threedimensional dobutamine stress echocardiography: comparison with conventional two-dimensional methods. Eur Heart J 2005;26:1625-32.
21. Pulerwitz T, Hirata K, Abe Y, Otsuka R, Herz S, Okajima K et al. Feasibility of using a real-time 3-dimensional technique for contrast dobutamine stress echocardiography. J Am Soc Echocardiogr 2006;19:540-5.
22. Takeuchi M, Otani S, Weinert L, Spencer KT, Lang RM. Comparison of contrast-enhanced real-time live 3-dimensional dobutamine stress echocardiography with contrast 2-dimensional echocardiography for detecting stress-induced wall-motion abnormalities. J Am Soc Echocardiogr 2006;19:294-9.
23. Walimbe V, Garcia M, Lalude O, Thomas J, Shekhar R. Quantitative realtime 3-dimensional stress echocardiography: a preliminary investigation of feasibility and effectiveness. J Am Soc Echocardiogr 2007;20:13- 22.
24. Yao J, De Castro S, Delabays A, Masani N, Udelson JE, Pandian NG. Bulls-eye display and quantitation of myocardial perfusion defects using three-dimensional contrast echocardiography. Echocardiography 2001;18:581-8.
25. Yao J, Takeuchi M, Teupe C, Sheahan M, Connolly R, Walovitch RC et al. Evaluation of a new ultrasound contrast agent (AI-700) using two-dimensional and three-dimensional imaging during acute ischemia. J Am Soc Echocardiogr 2002;15:686-94.
26. Chen LX, Wang XF, Nanda NC, Miller AP, Xie MX, Zhuang L et al. Real-time three-dimensional myocardial contrast echocardiography in assessment of myocardial perfusion defects. Chin Med J (Engl) 2004;117:337- 41.
27. Pemberton J, Li X, Hickey E, Karamlou T, Sandquist CA, Ungerleider R et al. Live real-time three-dimensional echocardiography for the visualization of myocardial perfusion - a pilot study in open-chest pigs. J Am Soc Echocardiogr 2005;18:956-8.
28. Toledo E, Lang RM, Collins KA, Lammertin G, Williams U, Weinert L et al. Imaging and quantification of myocardial perfusion using real-time three-dimensional echocardiography. J Am Coll Cardiol 2006;47:146-54.
29. Mor-Avi V, Lang RM. Three-dimensional echocardiographic evaluation of myocardial perfusion. Cardiol Clin 2007;25:273-82.
30. Iwakura K, Ito H, Okamura A, Kurotobi T, Koyama Y, Date M et al. Comparison of two- versus three-dimensional myocardial contrast echocardiography for assessing subendocardial perfusion abnormality after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol 2007;100:1502-10.